IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 24 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $129,375 | +6.9% | 120,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $121,000 | -4.7% | 120,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $127,000 | -8.0% | 120,000 | 0.0% | 0.00% | +200.0% |
Q1 2022 | $138,000 | +3.0% | 120,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $134,000 | -5.6% | 120,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $142,000 | 0.0% | 120,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $142,000 | +6.8% | 120,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $133,000 | -0.7% | 120,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $134,000 | – | 120,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 5,300,000 | $5,870,000 | 0.72% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,355,000 | $4,850,000 | 0.57% |
AQR Arbitrage LLC | 7,700,000 | $8,532,000 | 0.31% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $11,544,000 | 0.30% |
LINDEN ADVISORS LP | 26,849,000 | $29,850,000 | 0.22% |
WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $23,520,000 | 0.20% |
Jefferies Group LLC | 5,218,000 | $5,823,079 | 0.05% |
HBK INVESTMENTS L P | 10,000,000 | $11,104,000 | 0.05% |
Calamos Advisors LLC | 7,500,000 | $8,314,000 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 8,000,000 | $8,865,000 | 0.03% |